Drug Design Development and Therapy

Scope & Guideline

Pioneering the Future of Drug Design and Patient Care

Introduction

Welcome to the Drug Design Development and Therapy information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of Drug Design Development and Therapy, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN1177-8881
PublisherDOVE MEDICAL PRESS LTD
Support Open AccessYes
CountryNew Zealand
TypeJournal
Convergefrom 2007 to 2024
AbbreviationDRUG DES DEV THER / Drug Des. Dev. Ther.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressPO BOX 300-008, ALBANY, AUCKLAND 0752, NEW ZEALAND

Aims and Scopes

The journal 'Drug Design Development and Therapy' focuses on advancing the field of drug development and therapeutic strategies through rigorous research that encompasses a variety of methodologies and disciplines.
  1. Drug Discovery and Development:
    The journal emphasizes original research articles that explore novel drug candidates, their mechanisms of action, and the methodologies involved in the drug development process.
  2. Pharmacology and Toxicology:
    Articles in this area assess the pharmacokinetics, pharmacodynamics, and toxicological profiles of various compounds, providing critical insights into their therapeutic potential.
  3. Clinical Applications and Trials:
    The journal publishes clinical studies, trials, and retrospective analyses that evaluate the efficacy and safety of drugs and treatment protocols in real-world settings.
  4. Integrative Approaches in Medicine:
    Research that combines traditional medicine with modern pharmacological techniques, particularly those utilizing network pharmacology and systems biology, is a significant focus.
  5. Innovative Drug Delivery Systems:
    The journal covers advancements in drug delivery technologies, including nanotechnology and biopolymer-based systems, aimed at enhancing therapeutic efficacy and patient compliance.
  6. Natural Products and Traditional Medicine:
    There is a consistent focus on the pharmacological properties of natural compounds and traditional medicine formulations, illustrating their roles in modern therapeutic applications.
The journal has observed notable trends and emerging themes that highlight its dynamic nature and responsiveness to contemporary issues in drug design and therapy.
  1. Network Pharmacology and Systems Biology:
    There is a growing trend towards the use of network pharmacology and systems biology approaches to understand drug interactions, mechanisms of action, and to identify therapeutic targets.
  2. Personalized Medicine:
    Research focusing on personalized or precision medicine is on the rise, reflecting a shift towards tailoring therapies based on individual patient profiles and genetic backgrounds.
  3. Integrative and Complementary Approaches:
    There is an increasing interest in the integration of traditional medicine with modern pharmacological methods, exploring the efficacy of herbal and natural products in contemporary therapeutic applications.
  4. Nanotechnology in Drug Delivery:
    The application of nanotechnology in drug delivery systems is emerging as a critical area of focus, aimed at improving bioavailability and targeting specific tissues or cells.
  5. Longitudinal and Real-World Evidence Studies:
    The journal is increasingly publishing longitudinal studies and real-world evidence research that assess the long-term efficacy and safety of treatments in diverse patient populations.
  6. Immunotherapy and Biologics:
    There is a noticeable trend towards research in immunotherapeutic agents and biologics, reflecting the growing importance of these therapies in the treatment of various diseases, particularly cancers.

Declining or Waning

While the journal continues to thrive in several research areas, some themes have shown a decline in prominence, reflecting changing priorities and advancements in the field.
  1. Conventional Pharmaceutical Approaches:
    Research focused solely on conventional pharmaceutical drugs without consideration of integrative or novel approaches appears to be waning, as the field shifts towards more innovative and holistic strategies.
  2. Single-Agent Studies:
    There is a noticeable reduction in studies that evaluate the efficacy of single-agent therapies, as combination therapies and multi-target strategies become more favorable in clinical settings.
  3. Basic Science Studies:
    Research with a purely basic science focus, lacking translational or clinical relevance, is increasingly less common, as the journal emphasizes studies with direct implications for drug development and therapy.
  4. Short-Term Efficacy Studies:
    The focus on short-term efficacy and safety studies is diminishing, with a greater emphasis now being placed on long-term outcomes and the comprehensive assessment of therapeutic regimens.

Similar Journals

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Advancing pharmacological knowledge for a healthier tomorrow.
Publisher: DUSTRI-VERLAG DR KARL FEISTLEISSN: 0946-1965Frequency: 12 issues/year

INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, published by DUSTRI-VERLAG DR KARL FEISTLE in Germany, is a vital scholarly platform dedicated to advancing the field of pharmacology through rigorous research and innovative therapeutic strategies. Established in 1994, this journal has maintained its relevance in the evolving landscape of clinical pharmacology, achieving a Q3 rank in both general and medical pharmacology categories as of 2023. With an ISSN of 0946-1965, it is positioned as an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of drug therapy and pharmacological applications. Though it currently does not offer open access, its comprehensive scope covers a wide array of topics within pharmacology, promising to contribute significantly to scientific discussions and knowledge dissemination from 1994 to 2024. Whether you are looking for the latest studies or historical insights, the journal remains a fixture for anyone invested in the pharmacological sciences.

ACTA PHARMACEUTICA

Connecting scholars and practitioners with cutting-edge insights.
Publisher: SCIENDOISSN: 1330-0075Frequency: 4 issues/year

ACTA PHARMACEUTICA is a distinguished open-access journal published by SCIENDO, dedicated to advancing knowledge in the fields of medicine and pharmaceutical sciences. Established in 1992, the journal has made significant contributions to the scholarly community, providing a platform for innovative research and discussion. With a strong presence in both Q2 and Q3 quartiles across various categories including Pharmaceutical Science and Pharmacology, ACTA PHARMACEUTICA ranks favorably, positioning its contributions in the upper tiers of the field. The journal's commitment to open access since 2007 ensures that both practitioners and scholars have immediate access to cutting-edge developments, thereby fostering collaboration and knowledge sharing. With its scope spanning a broad spectrum of pharmaceutical and biomedical research, ACTA PHARMACEUTICA is an essential resource for researchers, professionals, and students keen to stay abreast of the latest advancements and trends in these vital areas of study.

Research in Pharmaceutical Sciences

Exploring the Frontiers of Drug Development
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 1735-5362Frequency: 6 issues/year

Research in Pharmaceutical Sciences is a premier, peer-reviewed journal published by Wolters Kluwer Medknow Publications, dedicated to advancing the field of pharmacology, toxicology, and pharmaceutics. With an impact factor that positions it in the second quartile of its category (Q2) and a respectable rank of 23 out of 80 in Scopus, this journal serves as an essential platform for researchers, professionals, and students alike, providing open access since 2015 to a wealth of pioneering studies and comprehensive reviews. Based in Mumbai, India, the journal encompasses a diverse range of topics within the pharmaceutical sciences, offering insights that address both theoretical and practical challenges in drug development and safety. As it converges from 2009 to 2024, Research in Pharmaceutical Sciences continues to be a vital source of knowledge, promoting innovation and fostering collaboration within the global scientific community.

PHARMACIA

Unlocking the future of pharmacy through open-access research.
Publisher: PENSOFT PUBLISHERSISSN: 0428-0296Frequency: 4 issues/year

PHARMACIA is a distinguished open-access journal, published by PENSOFT PUBLISHERS, that has been a pivotal platform for advancing the field of pharmaceutical sciences since 2007. This journal, with ISSN 0428-0296 and E-ISSN 2603-557X, is based in Bulgaria and continues to publish high-quality research and reviews relevant to pharmacy, pharmacology, and toxicology. Recognized in the Q3 category for Pharmaceutical Sciences and Pharmacology (medical), as well as Q2 in Pharmacy according to the latest rankings, PHARMACIA is celebrated for its commitment to fostering knowledge dissemination and innovation in drug development, therapeutic approaches, and pharmacological research. With a Scopus rank of #17 in Pharmacy and recognition in various health professions, the journal attracts contributions from researchers, professionals, and students seeking to impact the pharmaceutical landscape. Its convenient open-access format ensures that articles are readily available to a global audience, encouraging collaboration and advancement in the life sciences.

European Journal of Pharmacology

Unveiling groundbreaking research in pharmacokinetics and toxicology.
Publisher: ELSEVIERISSN: 0014-2999Frequency: 24 issues/year

The European Journal of Pharmacology, a prestigious publication by Elsevier, serves as a vital resource in the field of pharmacology, offering rich insights into drug development and therapeutic applications. Since its inception in 1967, this journal has evolved to encompass groundbreaking research, including pharmacokinetics, toxicology, and innovative pharmacological methodologies, making it an essential platform for researchers and professionals alike. With an impressive impact factor that places it in the Q1 category of pharmacological journals and a Scopus ranking of #49 out of 313, the journal is recognized in the 84th percentile within its category, solidifying its significance in the academic community. Although the journal is not open access, it continues to attract contributions from leading scientists worldwide, ensuring that cutting-edge findings are disseminated effectively. The European Journal of Pharmacology not only highlights advancements in drug discovery and clinical applications but also promotes interdisciplinary collaboration, ultimately contributing to the progress of healthcare globally.

INDIAN JOURNAL OF PHARMACOLOGY

Exploring the frontiers of pharmacology since 1978.
Publisher: WOLTERS KLUWER MEDKNOW PUBLICATIONSISSN: 0253-7613Frequency: 6 issues/year

INDIAN JOURNAL OF PHARMACOLOGY, published by Wolters Kluwer Medknow Publications, is a premier platform dedicated to advancing the field of pharmacology and its related disciplines. With a rich history since its inception in 1978, this journal aims to disseminate high-quality research findings, reviews, and clinical studies that contribute to the global understanding of drug action and therapeutic practices. As a valuable resource for researchers, professionals, and students alike, it operates within the Q3 quartile of the Pharmacology category, positioning itself as an influential contributor in the realm of medical pharmacology. The journal is committed to publishing rigorous scientific inquiry, fostering innovation, and bridging gaps between laboratory research and clinical application. Readers can access its wide-ranging articles to stay informed about the latest advancements in the field, reflecting its crucial role in shaping future pharmacological research and practice.

Chemical Biology & Drug Design

Advancing drug discovery through innovative chemical insights.
Publisher: WILEYISSN: 1747-0277Frequency: 12 issues/year

Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.

Drug Target Insights

Catalyzing Breakthroughs in Pharmaceutical Sciences.
Publisher: ABOUTSCIENCE SRLISSN: 1177-3928Frequency: 1 issue/year

Drug Target Insights is a prestigious peer-reviewed journal published by ABOUTSCIENCE SRL, catering to the dynamic field of pharmacology and medicinal biochemistry. With an Open Access policy since 2006, the journal aims to promote the dissemination of cutting-edge research and innovations that target drug discovery and therapeutic developments. Based in Milan, Italy, it boasts a notable impact within its research community, achieving a Q3 classification in the categories of Clinical Biochemistry and Medical Pharmacology in 2023, alongside a robust performance in the Q2 category for Pharmacology, Toxicology, and Pharmaceutics. The journal serves as a vital platform for researchers, professionals, and students seeking to advance their understanding of drug delivery systems, therapeutic targets, and pharmacodynamics. With a commitment to enhancing global access to crucial research findings, Drug Target Insights stands out as an essential resource for those engaged in the ever-evolving landscape of pharmaceutical sciences.

Acta Pharmaceutica Sinica B

Bridging Knowledge and Innovation in Pharmaceutics
Publisher: INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCESISSN: 2211-3835Frequency: 6 issues/year

Acta Pharmaceutica Sinica B is a prestigious open access journal that has been setting the standard in the field of pharmacology, toxicology, and pharmaceutics since its establishment in 2011. Published by the Institute of Materia Medica, Chinese Academy of Medical Sciences, the journal serves as a vital platform for researchers, professionals, and students seeking to disseminate innovative findings in drug development, pharmaceutical sciences, and therapeutic applications. With an impressive impact factor reflecting its high academic quality, Acta Pharmaceutica Sinica B has achieved Q1 status in the category of Pharmacology, Toxicology and Pharmaceutics as of 2023, ranking #1 out of 80 journals in General Pharmacology. This journal not only focuses on the latest advancements in drug research and formulation but also emphasizes interdisciplinary approaches, fostering collaborations that span various scientific domains. The accessible nature of the journal, combined with its rigorous peer-review process, ensures that crucial insights and breakthroughs reach a global audience swiftly and effectively. For those looking to stay at the forefront of pharmaceutical research, Acta Pharmaceutica Sinica B is an indispensable resource.

Frontiers in Pharmacology

Pioneering discoveries in pharmacokinetics, toxicology, and beyond.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Pharmacology, published by FRONTIERS MEDIA SA, stands as a leading open-access journal dedicated to advancing the field of pharmacology since its inception in 2010. With its ISSN 1663-9812, the journal is based in Switzerland and maintains a vital role in disseminating innovative research findings that span various disciplines within pharmacology, including pharmacokinetics, toxicology, and pharmacogenetics. In 2023, Frontiers in Pharmacology has achieved an impressive standing within the scientific community, being ranked in the Q1 category for both general and medical pharmacology, highlighting its critical contribution to the field with a Scopus ranking of #41 out of 272 in medical pharmacology and #76 out of 313 in pharmacology, toxicology, and pharmaceutics, placing it in the 75th and 85th percentiles, respectively. Researchers and practitioners benefit from its open-access model, which ensures widespread accessibility to groundbreaking research, fostering collaboration and innovation across the pharmaceutical sciences. With its commitment to excellence, Frontiers in Pharmacology serves as an essential resource for those looking to explore and contribute to the latest advancements in pharmacological research.